Sands Capital Management — RARE Trade History
Quarter-by-quarter changes in the ULTRAGENYX PHARMACEUTICAL IN position · CUSIP 90400D108
Currently held · 3.3 YearsFirst seen: 2023 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-13 | Reduce | 3,158,368 | -56,165 | -1.7% | $105.5M | 0.39% |
| 2026 Q1 | 2026-05-08 | Reduce | 3,214,533 | -271,191 | -7.8% | $67.3M | 0.26% |
| 2025 Q4 | 2026-02-13 | Reduce | 3,485,724 | -284,129 | -7.5% | $80.2M | 0.24% |
| 2025 Q3 | 2025-11-13 | Reduce | 3,769,853 | -173,632 | -4.4% | $113.4M | 0.31% |
| 2025 Q2 | 2025-08-13 | Reduce | 3,943,485 | -220,076 | -5.3% | $143.4M | 0.41% |
| 2025 Q1 | 2025-05-14 | Reduce | 4,163,561 | -134,442 | -3.1% | $150.8M | 0.51% |
| 2024 Q4 | 2025-02-13 | Reduce | 4,298,003 | -820,252 | -16.0% | $180.8M | 0.54% |
| 2024 Q3 | 2024-11-13 | Reduce | 5,118,255 | -236,495 | -4.4% | $284.3M | 0.86% |
| 2024 Q2 | 2024-08-13 | Add | 5,354,750 | 1,495,303 | +38.7% | $220.1M | 0.65% |
| 2024 Q1 | 2024-05-14 | Reduce | 3,859,447 | -258,561 | -6.3% | $180.2M | 0.50% |
| 2023 Q4 | 2024-02-13 | Add | 4,118,008 | 1,540,791 | +59.8% | $196.9M | 0.60% |
| 2023 Q3 | 2023-11-14 | Reduce | 2,577,217 | -96,421 | -3.6% | $91.9M | 0.31% |
| 2023 Q2 | 2023-08-15 | New | 2,673,638 | 2,673,638 | — | $123.3M | 0.38% |
| 2023 Q1 | 2023-05-12 | — | — | — | — | — | — |
| 2022 Q4 | 2023-02-13 | — | — | — | — | — | — |
| 2022 Q3 | 2022-11-09 | — | — | — | — | — | — |
| 2022 Q2 | 2022-08-12 | — | — | — | — | — | — |
| 2022 Q1 | 2022-05-13 | — | — | — | — | — | — |
| 2021 Q4 | 2022-02-11 | — | — | — | — | — | — |
| 2021 Q3 | 2021-11-03 | — | — | — | — | — | — |
| 2021 Q2 | 2021-08-16 | — | — | — | — | — | — |
| 2021 Q1 | 2021-05-17 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-17 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-17 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-11 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-14 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-13 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-14 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-14 | — | — | — | — | — | — |
| 2017 Q3 | 2017-11-14 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-14 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-13 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-14 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.